<DOC>
	<DOCNO>NCT01866566</DOCNO>
	<brief_summary>Through evaluate immunogenicity safety Varicella vaccine two dos immune procedure could supply scientific practical evidence two dos immune procedure promotion management .</brief_summary>
	<brief_title>The Safety Immunogenicity Research Live Attenuated Varicella Vaccine After 2 Doses Vaccination</brief_title>
	<detailed_description>Healthy participant age 1 12 year old never receive Varicella Vaccine divide three age group , 1 3 year old group , 4 6 year old group 7-12 year old group . In age group , participant randomly divide experiment group control group .</detailed_description>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participants Shanxi province 112 year old good healthy determine medical inquiry , physical examination , clinical judgment investor . 1 . Having fever ( axillary temperature＞37.0℃ ) enrollment ; 2 . Having disease history seizure , brain disease vaccination history allergy convulsion ; 3 . Antibiotics allergy ; 4 . Having problem intramuscular injection thrombocytopenia blood coagulation disorder ; 5 . Having immunodeficiency immunosuppression therapy , radiation therapy ; 6 . Having respiratory disease , acute infection , chronic disease HIV infection ; 7 . Having systemic skin rash , skin tinea , herpes ; 8 . Chronic liver kidney disease ; 9 . Heart disease , severe hypertension ; 10 . Have receive whole blood , plasma immunoglobulin therapy 3 month enrollment ; 11 . Have receive live attenuate vaccine vaccination 30 day enrollment ; 12 . Had infect Varicella virus display symptom ; 13 . Have receive one two dose Varicella vaccine enrollment ; 14 . Congenital malformation , growth disorder Down 's syndrome , diabetes , sickle cell anemia nervous disorder 15 . Guillainbarre syndrome 16 . Thyroid resection history thyroid disease treatment past 12 month ; 17 . Asthma 18 . Have participate clinical research ; 19 . Have serious adverse reaction vaccination , allergy , hive , breathe difficulty , angioneurotic edema .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>